Affiliation:
1. Institute for Health, Rutgers University, New Brunswick, NJ 08903.
Abstract
Cost-effectiveness analysis, a set of methods for estimating the costs and health effects of medical interventions, helps decision makers to compare alternative treatments and to decide which interventions are appropriate in which situations. This article outlines some fundamental principles of cost-effectiveness analysis and discusses the characteristics necessary if alternative therapies are to be more cost-effective than traditional drug treatment for hypertension. The discussion focuses primarily on the newer drugs like angiotensin converting enzyme inhibitors, alpha-adrenergic receptor blockers, and calcium antagonists.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference9 articles.
1. Russell LB: Is Prevention Better Than Cure? Washington DC Brookings Institution 1986 pp 1-134
2. Kaplan RM Bush JW: Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982;l:161-180
3. Weinstein MC Stason WB: Hypertension: A Policy Perspective. Cambridge Mass Harvard University Press 1976 pp 1-281
4. Cutting costs: Hypertension drugs;Gould G;Am Health,1987
5. Russell LB: Evaluating Preventive Care: Report on a Workshop. Washington DC: Brookings Institution 1987 pp 1-107
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献